Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Douwe F. Postma, Cornelis H. van Werkhoven, Darren P.R. Troeman, Sanjay U.C. Sankatsing, Jan Jelrik Oosterheert, Marc J.M. Bonten. Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia?. Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017

Member's Comments

No comment yet.

Related content which might interest you: Admission glucose concentrations independently predict early mortality in patients with community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 482s Year: 2007 Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia. Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017 Admission serum glucose levels are a risk factor predicting short- and long-term mortality in community acquired pneumonia Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia Source: Eur Respir J 2009; 34: 932-939 Year: 2009 Predictive factors of in-hospital mortality of patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 Initial management of pneumonia and sepsis: factors associated with improved outcome Source: Eur Respir J 2011; 39: 156-162 Year: 2012 Initial management of pneumonia and sepsis: factors associated with improved outcome Source: Eur Respir J 2012; 39: 156-162 Year: 2012 Correlation between pneumonia severity index and mortality within 30 days after the diagnosis of community-acquired pneumonia in elderly subjects Source: Eur Respir J 2006; 28: Suppl. 50, 741s Year: 2006 Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Oxy-Met score: a new physiological index to predict mortality in community-acquired pneumonia Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017 Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Factors influencing in-hospital mortality in community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Predictors of rehospitalization after admission for community-acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Factors associated with community-acquired pneumonia in-hospital mortality in Portugal Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021